APA (7th ed.) Citation

HM, Q., LP, Q., XZ, P., & LS, M. (2018). Upregulated miR-222 targets BCL2L11 and promotes apoptosis of mesenchymal stem cells in preeclampsia patients in response to severe hypoxia. International journal of clinical and experimental pathology, 11(1), 110.

Chicago Style (17th ed.) Citation

HM, Qu, Qu LP, Pan XZ, and Mu LS. "Upregulated MiR-222 Targets BCL2L11 and Promotes Apoptosis of Mesenchymal Stem Cells in Preeclampsia Patients in Response to Severe Hypoxia." International Journal of Clinical and Experimental Pathology 11, no. 1 (2018): 110.

MLA (9th ed.) Citation

HM, Qu, et al. "Upregulated MiR-222 Targets BCL2L11 and Promotes Apoptosis of Mesenchymal Stem Cells in Preeclampsia Patients in Response to Severe Hypoxia." International Journal of Clinical and Experimental Pathology, vol. 11, no. 1, 2018, p. 110.